Prostate Cancer

Clinical data, expert insights, and treatment advancements presented at the ASCO Genitourinary Cancers Symposium prostate cancer sessions, focusing on practice-informing updates.

Prostate Cancer

EV Plus Pembrolizumab and Systemic Therapy Advances in GU Oncology - OncUpdates.

Prostate Cancer

03/16/2026

Community Takeaways From ASCO GU 2026

Regina Barragan-Carrillo, MDRaji Shameem, MD

Advanced molecular testing and targeted therapies for prostate cancer research and treatment.

Prostate Cancer

03/16/2026

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

Brooke Kania, DOSindhuja Kadambi, MD, MS

Postoperative radiation and personalized therapy in GU cancers, featuring two smiling female doctors against a cityscape background.

Prostate Cancer

03/16/2026

A Personalized Approach to Treating GU Cancers

Sophia Kamran, MDNatalie Reizine, MD

Advanced medical professionals discussing Radium-223 Plus Enzalutamide in mCRPC with bone metastases in an urban hospital setting.

Prostate Cancer

03/14/2026

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sindhuja Kadambi, MD, MSKarine Tawagi, MD

PARP inhibitor combination therapy in metastatic prostate cancer, featuring Jeffrey Zhong, MD, and Karan Jatwani, MD, with a cityscape background.

Prostate Cancer

03/11/2026

PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer

Karan Jatwani, MDJeffrey Zhong, MD

Advanced prostate cancer treatment research featuring Karan Jatwani, MD, and Alan Bryce, MD, with a city skyline background.

Prostate Cancer

03/06/2026

Capivasertib Plus Abiraterone in Metastatic Prostate Cancer

Alan Bryce, MDKaran Jatwani, MD